rxstat › Shortages › Ethinyl Estradiol Norethindrone

Ethinyl Estradiol Norethindrone shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ethinyl Estradiol Norethindrone products are in shortage in Canada (4 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 19, 2027.
Products affected
4 / 10
In shortage since
Jun 6, 2025
Est. full return
Mar 19, 2027
Reports on file
36
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
BREVICON 1/35 TABLETS (21-DAY PACK)
0.035MG 1MG · TABLET · PFIZER CANADA ULC
DIN 02189054 · since ?, est. end Mar 19, 2027 · Disruption of the manufacture of the drug.
Active shortage
BREVICON 0.5/35 TABLETS (28-DAY PACK)
.5MG .035MG · TABLET · PFIZER CANADA ULC
DIN 02187094 · since Jun 6, 2025, est. end Mar 19, 2027 · Disruption of the manufacture of the drug.
Active shortage
BREVICON 1/35 TABLETS (28-DAY PACK)
1MG 0.035MG · TABLET · PFIZER CANADA ULC
DIN 02189062 · since Jan 2, 2026, est. end Mar 19, 2027 · Disruption of the manufacture of the drug.
Active shortage
BREVICON 0.5/35 TABLETS (21-DAY PACK)
0.035MG 0.5MG · TABLET · PFIZER CANADA ULC
DIN 02187086 · since Mar 17, 2026, est. end Mar 19, 2027 · Disruption of the manufacture of the drug.
Resolved
BREVICON 1/35 TABLETS (21-DAY PACK)
0.035MG 1MG · TABLET · PFIZER CANADA ULC
DIN 02189054 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
BREVICON 1/35 TABLETS (21-DAY PACK)
0.035MG 1MG · TABLET · PFIZER CANADA ULC
DIN 02189054 · ended Jul 31, 2025 · Disruption of the manufacture of the drug.
Resolved
BREVICON 0.5/35 TABLETS (21-DAY PACK)
0.5MG 0.035MG · TABLET · PFIZER CANADA ULC
DIN 02187086 · ended Jul 30, 2025 · Disruption of the manufacture of the drug.
Discontinued
SELECT 1/35 (28-DAY)
0.035MG 1.0MG · TABLET · PFIZER CANADA ULC
DIN 02199297
Resolved
SELECT 1/35 (21-DAY)
0.035MG 1.0MG · TABLET · PFIZER CANADA ULC
DIN 02197502 · ended May 16, 2025 · Disruption of the manufacture of the drug.
Resolved
SELECT 1/35 (28-DAY)
0.035MG 1.0MG · TABLET · PFIZER CANADA ULC
DIN 02199297 · ended May 16, 2025 · Disruption of the manufacture of the drug.
Resolved
BREVICON 1/35 TABLETS (28-DAY PACK)
0.035MG 1MG · TABLET · PFIZER CANADA ULC
DIN 02189062 · ended Feb 11, 2025 · Disruption of the manufacture of the drug.
Resolved
BREVICON 1/35 TABLETS (21-DAY PACK)
0.035MG 1MG · TABLET · PFIZER CANADA ULC
DIN 02189054 · ended Feb 3, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 36 reports. All reports are on file with Health Canada.

What's happening

Ethinyl Estradiol Norethindrone is currently affected by 4 active shortage reports filed with Health Canada by PFIZER CANADA ULC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ethinyl Estradiol Norethindrone is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AA).

Recent changes

Common questions

When will Ethinyl Estradiol Norethindrone be back in stock in Canada?

The latest manufacturer estimate is Mar 19, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ethinyl Estradiol Norethindrone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (hormonal contraceptives for systemic use)

Partial shortageDrospirenone Ethinyl Estradiol1 of 9 reported products affected · est. return Aug 10, 2026Partial shortageEthinyl Estradiol Desogestrel1 of 10 reported products affected · est. return Aug 20, 2026Partial shortageEthinyl Estradiol Levonorgestrel3 of 18 reported products affectedPartial shortageEthinyl Estradiol Levonorgestrel Ethinyl Estradiol1 of 1 reported products affectedPartial shortageNorethindrone1 of 4 reported products affected · est. return Aug 10, 2026Partial shortageNorgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol2 of 10 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.